-
11:42:06 PM

AMRX Stock News

08/29/23 4:01 PM
NYSE : AMRX
Delegation from U.S. Department of Health and Human Services, U.S. Food and Drug Administration, and Local Government Officials Visit Amneal Manufacturing Site in India
Amneal Pharmaceuticals, Inc. today announced that a delegation of senior members of the U.S. Department of Health and Human Services and U.S. Food and Drug Administration together with local government officials recently visited the Company’ s manufacturing facility in Matoda, India. Loyce Pace, the Assistant Secretary for Global Affairs, who is the lead on...
RHEA-AI
neutral
08/24/23 4:01 PM
NYSE : AMRX
clinical trial
JAMA Neurology Publishes Phase 3 Study Results Comparing IPX203 to Immediate-Release Carbidopa/Levodopa for Parkinson’s Disease
Amneal Pharmaceuticals, Inc. today announced that JAMA Neurology has published results from the RISE-PD clinical study assessing the efficacy and safety of IPX203 versus optimized immediate-release carbidopa/levodopa for the treatment of Parkinson’ s disease. The study met its primary and secondary endpoints finding that IPX203 provided more hours...
RHEA-AI
neutral
07/03/23 2:01 PM
NYSE : AMRX
fda approval
Amneal Launches Authorized Generic for Xyrem® (sodium oxybate) and Receives FDA Approval for Five Complex Generics in the Second Quarter
In addition, the Company announced it has received Abbreviated New Drug Application approvals from the U.S. Food and Drug Administration for five complex generics products. Three recently approved products are injectables, including dexmedetomidine injection which is currently on the U.S. FDA shortage product list. “The launch of an authorized generic...
RHEA-AI
neutral